Press release
What's driving the Angina Pectoris Treatment Market Growth? Prominent Players: Abbott., AstraZeneca, Bayer AG, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Allergan and more
Browse Complete Report Details at
https://www.fortunebusinessinsights.com/industry-reports/angina-pectoris-treatment-market-100377
Top Leaders Overview:
Some of the leading companies in the global Angina Pectoris Treatment Market are
• Abbott.
• AstraZeneca
• Bayer AG
• Bristol-Myers Squibb
• F. Hoffmann-La Roche Ltd
• Allergan
• Gilead Sciences
• GlaxoSmithKline Pharma GmbH
• Novartis
• Pfizer
• Sanofi and other key players.
The report offers global angina pectoris treatment market share assessment for the country as well as regional level segments. It further provides strategic recommendations for the new entrants in the market. Furthermore, the report aids in providing supply chain trends by mapping the ongoing technological advancements.
Segmentation
By Drug Class
• Beta-Blockers
• Calcium Antagonists
• Anti-coagulant
• Anti-Platelets
• Nitrates
By Disease Type
• Stable or chronic angina
• Unstable angina
• Variant and microvascular angina
By Distribution Channel
• Online pharmacies
• Hospital pharmacies
• Retail pharmacies
New Innovative Product Launches to Favor Growth in North America
The global angina pectoris treatment market is geographically divided into Latin America, Asia Pacific, Europe, the Middle East and Africa, and North America. Out of these, North America is projected to lead the global market during the forecast period. It would occur due to the introduction of several guidelines involved in managing and diagnosing patients suffering from stable ischemic heart disease.
Get Sample PDF Brochure at
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/angina-pectoris-treatment-market-100377
New product launches also contribute to the growth in this region. Asia Pacific, on the other hand, is considered to remain in the second-fastest-growing market due to the rising economies in the healthcare sector.
Janssen Receives FDA Approval for its Rivaroxaban (Xarelto) to Expand its Usage
In October 2018, the FDA officials declared its approval for Janssen’s rivaroxaban (Xarelto). The oral anticoagulant was first approved in 2011. It is now meant to reduce the risk of acute cardiovascular (CV) events, namely, stroke, myocardial infarction (MI), and death in those with chronic peripheral or coronary artery disease (PAD/CAD). FDA approval makes rivaroxaban the only Factor Xa inhibitor that is for the patients suffering from these conditions. Janssen is a renowned pharmaceutical company based in Belgium.
In spite of the usage of guideline-recommended therapies, sufferers of chronic PAD or CAD are at high risk of having an irreversible and devastating CV event. The latest Xarelto vascular 2.5mg dose is to bed used with aspirin. It represents a breakthrough for patients with chronic PAD and CAD.
AstraZeneca Enters into Strategic Collaboration with Recordati to Deliver Seloken in Europe
AstraZeneca, a multinational pharmaceutical and biopharmaceutical company, headquartered in the U.K., announced that it has partnered up with Recordati, an Italy-based pharmaceutical company in May 2017. The main of the collaboration is to gain commercial rights to Seloken ZOK (metoprolol succinate) and associated Logimax fixed-dose combination treatments in Europe. Metoprolol succinate aids in controlling heart failure, angina, and hypertension. AstraZeneca received a payment of USD 300 from Recordati after the completion of this partnership. AstraZeneca will develop and supply the medicines to the latter under another supply agreement. Product sales for Logimax and Seloken brands were USD 100 million in Europe, in 2016. AstraZeneca will commercialize these medicines in all the markets where it holds the rights.
Speak To Analyst at
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/angina-pectoris-treatment-market-100377
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the Angina Pectoris Treatment Market Growth? Prominent Players: Abbott., AstraZeneca, Bayer AG, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Allergan and more here
News-ID: 1854107 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for AstraZeneca
Hypereosinophilic Syndrome Market Revenue to Expand Significantly by 2032, State …
The Key Hypereosinophilic Syndrome Companies in the market include - GlaxoSmithKline, AstraZeneca, Novartis, M.D. Anderson Cancer Center, AstraZeneca, and others.
DelveInsight's "Hypereosinophilic Syndrome Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Hypereosinophilic Syndrome, historical and forecasted epidemiology as well as the Hypereosinophilic Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth…
DNA Repair Drugs Market May See a Big Move | Major Giants- AbbVie, AstraZeneca, …
The latest study released on the Global DNA Repair Drugs Market by HTF MI evaluates market size, trend, and forecast to 2030. The DNA Repair Drugs market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key…
Calcium Channel Antagonist Market Will Reflect Significant Growth Prospects By 2 …
The Calcium Channel Antagonist report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=7764202
The Calcium…
Nasal Polyposis Market to Witness Growth by (2022-2032), Estimates DelveInsight …
The Nasal Polyposis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Nasal Polyposis pipeline products will significantly revolutionize the Nasal Polyposis market dynamics.
DelveInsight's "Nasal Polyposis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Nasal Polyposis, historical and forecasted epidemiology as well as the Nasal Polyposis market trends in the…
Global Influenza Vaccines Market: Emerging Trends, Major Key Players Astrazeneca …
According to the report, The global Influenza Vaccines market is expected to grow from $ billion in 2020 to $ billion in 2028 at a CAGR of 15%.
Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006954
The latest research report published by Evolve Business Intelligence examines the impacts of numerous market aspects on the global INFLUENZA VACCINES industry including a look at the current market size and forecasts for key segments and…
What's driving the Cannula Market Growth? Prominent Players Merck, AstraZeneca, …
The global cannula market is estimated to grow to USD 222.09 million by 2026 growing at a substantial CAGR during the forecast period of 2019 to 2026. The rise in market value can be factored to the growing preference of minimally invasive surgical procedures from the patients.Global Cannula Market By Product (Vascular Cannula, Cardiac Cannula, Arthroscopy Cannula, Dermatology Cannula, Nasal Cannula, Others), Type (Neonatal, Straight, Winged, Wing with Port, Winged…
